Cargando…
The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing
SIMPLE SUMMARY: Cancer cells frequently have an altered metabolism to support their increased proliferative and invasive activity. Perhexiline, a drug used to treat some cardiovascular diseases, inhibits some of the reported changes in the metabolism of cancer cells. We show that treatment with this...
Autores principales: | Dhakal, Bimala, Li, Celine Man Ying, Li, Runhao, Yeo, Kenny, Wright, Josephine A., Gieniec, Krystyna A., Vrbanac, Laura, Sammour, Tarik, Lawrence, Matthew, Thomas, Michelle, Lewis, Mark, Perry, Joanne, Worthley, Daniel L., Woods, Susan L., Drew, Paul, Sallustio, Benedetta C., Smith, Eric, Horowitz, John D., Maddern, Guy J., Licari, Giovanni, Fenix, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869789/ https://www.ncbi.nlm.nih.gov/pubmed/35205791 http://dx.doi.org/10.3390/cancers14041043 |
Ejemplares similares
-
Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation
por: Dhakal, Bimala, et al.
Publicado: (2023) -
Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects
por: Dhakal, Bimala, et al.
Publicado: (2023) -
Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2023) -
Enantioselectivity in the tissue distribution of perhexiline contributes to different effects on hepatic histology and peripheral neural function in rats
por: Licari, Giovanni, et al.
Publicado: (2018) -
Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021)